Literature DB >> 1856416

Comparison of coronary vasodilation with intravenous dipyridamole and adenosine.

J D Rossen1, J E Quillen, A G Lopez, R G Stenberg, C L Talman, M D Winniford.   

Abstract

Although both intravenous dipyridamole and adenosine have been used to produce coronary vasodilation during cardiac imaging, the relative potency of the commonly administered doses of these agents has not been evaluated. Accordingly, the coronary and systemic hemodynamic effects of intravenous adenosine (140 micrograms/kg per min) and intravenous dipyridamole (0.56 mg/kg over 4 min) were compared with a maximally dilating dose of intracoronary papaverine in 15 patients. Coronary blood flow responses were assessed using a Doppler catheter in a nonstenotic coronary artery. The protocol was discontinued in two patients because of transient asymptomatic atrioventricular (AV) block during adenosine infusion. The mean heart rate increased more with adenosine (11 +/- 9 beats/min) and dipyridamole (11 +/- 7 beats/min) than with papaverine (4 +/- 3 beats/min, p less than 0.05 vs. adenosine and papaverine). The mean arterial pressure decreased less with dipyridamole (-10 +/- 3 mm Hg) and papaverine (-9 +/- 4 mm Hg) than with adenosine (-16 +/- 5 mm Hg, p less than 0.01 vs. dipyridamole and papaverine). The peak/rest coronary blood flow velocity ratio was greater with papaverine (3.9 +/- 1.1) than with adenosine (3.4 +/- 1.2, p less than or equal to 0.05 vs. papaverine) or dipyridamole (3.1 +/- 1.2, p less than 0.01 vs. papaverine). A larger decrease in coronary resistance as measured by the coronary vascular resistance index occurred with papaverine (0.25 +/- 0.06) and adenosine (0.26 +/- 0.09) than with dipyridamole (0.31 +/- 0.10, p less than 0.01 vs. papaverine, p less than 0.05 vs. adenosine).(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1856416     DOI: 10.1016/0735-1097(91)90604-8

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  32 in total

Review 1.  Role of nuclear cardiac imaging in myocardial infarction: postinfarction risk stratification.

Authors:  John J Mahmarian; Girish Dwivedi; Tultul Lahiri
Journal:  J Nucl Cardiol       Date:  2004 Mar-Apr       Impact factor: 5.952

Review 2.  Role of PET in the evaluation and understanding of coronary physiology.

Authors:  Thomas H Schindler; Xiao-Li Zhang; Gabriella Vincenti; Leila Mhiri; René Lerch; Heinrich R Schelbert
Journal:  J Nucl Cardiol       Date:  2007-07       Impact factor: 5.952

3.  Symptom-limited exercise during vasodilator stress: best of both worlds?

Authors:  Kevin A Bybee; Timothy M Bateman
Journal:  J Nucl Cardiol       Date:  2008 Jan-Feb       Impact factor: 5.952

4.  Using multidetector computed tomography in a swine model to assess the effects of sublingual nitroglycerin and intravenous adenosine on epicardial coronary arteries.

Authors:  Wesley A Clarkson; Carlos Santiago Restrepo; Terry D Bauch; Bernard J Rubal
Journal:  Comp Med       Date:  2009-12       Impact factor: 0.982

Review 5.  Practicing safe SPECT: caffeine abstinence in nuclear myocardial perfusion imaging.

Authors:  Kristina E Powles; Renee C Hessian; Terrence D Ruddy
Journal:  J Nucl Cardiol       Date:  2008 Sep-Oct       Impact factor: 5.952

6.  Assessment of the arterial input function for estimation of coronary flow reserve by single photon emission computed tomography: comparison of two different approaches.

Authors:  Giovanni Storto; Andrea Soricelli; Teresa Pellegrino; Mario Petretta; Alberto Cuocolo
Journal:  Eur J Nucl Med Mol Imaging       Date:  2009-12       Impact factor: 9.236

Review 7.  Evaluation of ischemic heart disease.

Authors:  Dipan J Shah; Han W Kim; Raymond J Kim
Journal:  Heart Fail Clin       Date:  2009-07       Impact factor: 3.179

8.  Preserved coronary flow reserve effectively excludes high-risk coronary artery disease on angiography.

Authors:  Masanao Naya; Venkatesh L Murthy; Viviany R Taqueti; Courtney R Foster; Josh Klein; Mariya Garber; Sharmila Dorbala; Jon Hainer; Ron Blankstein; Frederick Resnic; Marcelo F Di Carli
Journal:  J Nucl Med       Date:  2014-01-09       Impact factor: 10.057

Review 9.  Pharmacologic stress testing: mechanism of action, hemodynamic responses, and results in detection of coronary artery disease.

Authors:  A S Iskandrian; M S Verani; J Heo
Journal:  J Nucl Cardiol       Date:  1994 Jan-Feb       Impact factor: 5.952

10.  Are the differences between adenosine and dipyridamole clinically relevant?

Authors:  A S Iskandrian
Journal:  J Nucl Cardiol       Date:  1996 May-Jun       Impact factor: 5.952

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.